The health care markets are undoing rapid technology evolution. In emerging markets of Asia, the challenge is to reach a vast part of population with minimal access to health care and provide the necessary care at affordable costs. The investments required are significant wherein both public and private sector have roles to play. One of the growth areas which is likely to see significant investments is diagnostic especially for infectious diseases.
We have assisted manufacturers of APIs and FDF to find suitable export markets and customers. We have also done work with manufacturer of molecular diagnostic instrument and kits to build a suitable entry strategy for Indian market including identifying channel partners, potential collaborations with large customers, local contract manufacturing potential and opportunities.
We have proven track record of successfully executing several cross border JVs, Technology Transfer & M&A transactions.
We have partnered successfully with mid sized and large system integrators, technology providers and EPC contractors for specific program/project.
For large markets like India the challenge for international companies is to build credible and sustainable sales and distribution channels to fully exploit the market potential.